Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections.
about
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionPharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.Elucidating and engineering thiopeptide biosynthesis.In Vitro Biosynthesis of the Core Scaffold of the Thiopeptide ThiomuracinNatural products as probes in pharmaceutical research.Elfamycins: inhibitors of elongation factor-Tu.Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era.New antibiotics in clinical trials for Clostridium difficile.Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.Advances in the diagnosis and treatment of Clostridium difficile infections.RiPP antibiotics: biosynthesis and engineering potential.Novel Antimicrobials for the Treatment of Clostridium difficile Infection.
P2860
Q30235446-85943612-0529-4B93-B519-AA87EE6337DBQ30240264-3B147BF8-8090-4957-ADD0-B9E624541B3DQ35076880-65EBCE03-BF1C-45A2-A19B-A40378AA7940Q36369930-95478793-D73F-4282-8869-28C27B763E9FQ36761831-99A4DBE0-ECAF-4F1B-AC5C-2FB946FD8B59Q38599715-6899FC8C-8EA3-45BF-982C-BE9FE7AF3C35Q38657231-2288FB29-0D26-4088-BC3A-7F19DAE6D264Q38679612-FE32F82F-F558-4830-8471-729B8C0A052EQ38719092-2195BDAF-AC21-4FAD-B17F-7B259C9C928EQ38751212-B69AEB22-ACE1-4424-BC8C-4E2C8C68BFA2Q38928841-41D832CF-6FD6-4A8F-A7DC-01E4DC041F8FQ40615409-9860FEAE-C84A-4ED8-8CE3-54979E2861A6Q41596897-F5011186-86C8-4175-ADD8-44A61CD9865CQ50055623-1DC2467E-9C09-4B2A-B733-3C0CE1263C9CQ52658123-A5655CC0-E623-4A77-81D8-4BF8922FDFD5Q55405974-E22BBD93-2AF7-4DE0-8CF0-4CD8AF557784
P2860
Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multicenter, randomized clinic ...... stridium difficile infections.
@ast
Multicenter, randomized clinic ...... stridium difficile infections.
@en
Multicenter, randomized clinic ...... stridium difficile infections.
@nl
type
label
Multicenter, randomized clinic ...... stridium difficile infections.
@ast
Multicenter, randomized clinic ...... stridium difficile infections.
@en
Multicenter, randomized clinic ...... stridium difficile infections.
@nl
prefLabel
Multicenter, randomized clinic ...... stridium difficile infections.
@ast
Multicenter, randomized clinic ...... stridium difficile infections.
@en
Multicenter, randomized clinic ...... stridium difficile infections.
@nl
P2093
P2860
P356
P1476
Multicenter, randomized clinic ...... stridium difficile infections.
@en
P2093
Adam Bressler
Christine Lee
Jennifer A Leeds
Jens Praestgaard
Johanne Blais
Karl Weiss
Kathleen Mullane
Kristina Dabovic
Martha Buitrago
Peter Pertel
P2860
P304
P356
10.1128/AAC.04251-14
P407
P577
2014-12-22T00:00:00Z